Clinical Trial: Colchicine for Diabetic Nephropathy Trial

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: The Effect of Colchicine Treatment on the Progression of Proteinuria in Patients With Diabetic Nephropathy.

Brief Summary: Forty patients with diabetic nephropathy will be treated with colchicine up to 2 mg, or placebo, for 18 months. A follow up will be performed after 12 additional months. The primary outcome will be a significant reduction or stabilization of proteinuria during the 18 month treatment period.